Lenalidomide and the Expanding Toolkit to Manage Kaposi Sarcoma

Lenalidomide recently was shown to have clinical activity in patients with human immunodeficiency virus-associated Kaposi sarcoma. Immunomodulatory imine drugs thus provide another tool in the treatment of this challenging neoplasm.

Automated summary

Lenalidomide has been found to be clinically effective in patients with human immunodeficiency virus-associated Kaposi sarcoma, providing another option for the treatment of this challenging neoplasm.